Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HyperStem
- Development stage
- Unknown
- Lead developer
- Stem Cell Worx
- Modality
- Small Molecules, Peptides
- Administration
- Inhalation, Parenteral
01
Overview
HyperStem is a dietary supplement marketed as a natural stem cell mobilizer, primarily developed by Stem Cell Worx. It is formulated as an intra-oral spray to facilitate sublingual absorption, thereby bypassing the digestive system and increasing the bioavailability of its active ingredients. The formulation consists of high-grade bovine colostrum (standardized for high levels of IgG and IGF-1), trans-resveratrol, and fucoidan. The supplement's primary mechanism of action is to stimulate the mobilization of adult stem cells from the bone marrow into the systemic circulation, which is intended to support tissue repair, immune system health, and overall regenerative capacity. While not classified as a pharmaceutical drug by the FDA, it is utilized in the wellness industry for anti-aging and recovery purposes.
- Brand names
- HyperStem
- Other names
- Stem Cell Worx HyperStem
02
Targets
IGF-1R (Insulin-like growth factor 1 receptor)SELL (L-selectin)SIRT (Sirtuin family)
Beyond the preview
Go deeper on HyperStem.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HyperStem.